This Kalorama Information report details the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. The global market for prescription dermatology drugs includes products in the following categories:
• Prescription Acne and Rosacea Drugs
• Prescription Antiaging and Photodamage Drugs
• Prescription Dermatitis and Seborrhea Drugs
• Prescription Fungal Infection Drugs
• Prescription Hair Loss and Hair Removal Drugs
• Prescription Hyperpigmentation/Melasma Drugs
• Prescription Psoriasis Drugs
• Prescription Skin Cancer Drugs
• Other Prescription Skin Disorder Drugs
The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products. Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities. By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology. This transition will play a role in the future development of the dermatological industry over the forecast period. The global pharmaceutical sector has little choice but to continue expanding through mergers and acquisitions for some time to come. It's a very dynamic time for the industry focusing on a worldwide market, and among the trends covered in this report is:
• Patient Compliance
• Cosmetic Dermatologists
• Melanoma Survival Rates Falter
• Phosphatidylglycerol and Psoriasis
• New Itch Gene Found
• New Filler Options
• Consumer Confusion
• Genetic Link to Psoriasis
• Biologic Dermatology
• Rx-to-OTC Switches
• Cosmeceuticals
• Antioxidants
• Polypeptides
• Teledermatology
• Reimbursement Issues
• Accutane IPledge Program
• Laser Therapy
• Narrowband Ultraviolet B
• Photodynamic Therapy
• New Oral Medications and Research for Acne
• Synthetic Lipids for Skin Healing
• Importance of Drug Delivery
The information and analysis presented in this report are based on extensive interviews with senior management of top companies in the dermatology market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 42 industry executives and product managers to validate and obtain expert opinion on current and future trends in the dermatological market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.
The following companies are profiled in this report:
• Allergan Inc.
• Allergan Inamed Corporation
• Barrier Therapeutics, Inc
• Bayer AG
• PharmaDerm Pharmaceuticals, Inc
• Bristol-Myers Squibb
• Collagenex (now Galderma) Pharmaceuticals
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Mylan Pharmaceuticals, Inc,
• Novartis Pharmaceuticals Corporation
• Nycomed Inc.
• Pfizer, Inc.
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering (now Merck)-Plough Corporation
• Sinclair Pharma Plc.
• SkinMedica
• Stiefel Laboratories, Inc.
• Valeant Pharmaceuticals, Inc.
All market data pertains to the global market at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2009. Historical data are provided for each of the years 2007 to 2009, and forecast data are provided for each of the years 2009 through 2014. Historical, base year, and forecast data are provided for each market segment. Market shares are provided for each market segment for the 2009 base year.
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
Introduction
Scope and Methodology
Size and Growth of the Market
Issues and Trends Affecting Market
Competitor Analysis
CHAPTER TWO: INTRODUCTION
Structure and Function of the Skin
Epidermis
Dermis
Subcutaneous Tissue
Epidermal Appendages
Functions of the Skin
Effects of Aging on the Skin
Dermatological Conditions and Treatment
Pharmacokinetics
Drug Absorption
Distribution
Bioavailability
Drug Delivery Methods
Demographics of Skin Disorders, Incidence, and Prevalence
CHAPTER THREE: ISSUES AND TRENDS
Patient Compliance
Cosmetic Dermatologists
Melanoma Survival Rates Falter
Phosphatidylglycerol and Psoriasis
New Itch Gene Found
New Filler Options
Consumer Confusion
Genetic Link to Psoriasis
Biologic Dermatology
Rx-to-OTC Switches
Cosmeceuticals
Antioxidants
Polypeptides
Teledermatology
Reimbursement Issues
Accutane IPledge Program
Laser Therapy
Narrowband Ultraviolet B
Photodynamic Therapy
New Oral Medications and Research for Acne
Synthetic Lipids for Skin Healing
Importance of Drug Delivery
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
Description of Disorders
Description of Products
Benzoyl Peroxide
Description of Products
Current Suppliers
Retinoids
Topical Formulations
Systemic Formulations
Current Suppliers
Antibiotics
Description of Products
Current Suppliers
Oral Contraceptives
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
Overview
Description of Products
Keratolytics
Moisturizers
Retinoids
Sunscreens
Other Agents
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
Overview
Description of Products
Topical Corticosteroids
Systemic Corticosteroids
Other Products
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
Overview
Description of Products
Systemic Formulations
Terbinafine
Itraconazole
Fluconazole
Griseofulvin
Ketoconazole
Current Suppliers
Topical Formulations
Polyenes
Azoles
Allylamines and Benzylamines
Other Topical Formulations
New Products
Current Suppliers
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
Overview
Description of Products
Antiandrogens
Androgen Inhibitors
Oral Contraceptives
Other Treatments
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION / MELASMA DRUGS
Overview
Description of Products
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
Overview
Description of Products
Topical Psoriasis Products
Anthralin
Coal Tar
Methoxsalen
Second-generation Retinoids
Tazarotene
Topical Vitamin D
Vitamin D Analogs
Vanos
Systemic Psoriasis Preparations
Betamethasone
Cortisone Acetate
Cyclosporine
Hydrocortisone
Methotrexate
Olopatadine Hydrochloride
Tacrolimus
Light Therapy
Biologics
Research and Development
Market Size and Growth
Global Market by Type
Markets by Geographical Region
United States
Europe
Japan
Rest of World
Future of the Market
Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
Overview
Nonmelanoma Skin Cancers
Actinic Keratoses
Basal Cell Carcinoma
Squamous Cell Carcinoma
Cutaneous T-cell Lymphoma
Dysplastic Nevus Syndrome
Malignant Melanoma
Description of Products
5-Fluorouracil
Mechlorethamine/Nitrogen Mustard
Carmustine/BCNU (Topical)
Vinblastine (Intralesional) and Others
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS-ANTIVIRALS AND ANTIPARASITICS
Overview
Antivirals
Antiparasitics
Description of Products
Topical Antivirals
Antiviral Drugs
Immunoenhancing Drugs
Current Suppliers
Antiparasitic Agents
Current Suppliers
Other Skin Related Products
Research and Development
Market Size and Growth
Global Market
Markets by Geographical Region
United States
Europe
Japan
Rest of World
The Future of the Market
Competitive Analysis
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
Overview
Total Market Size and Forecast
Market and Competitive Analysis
CHAPTER FOURTEEN: CORPORATE PROFILES
Allergan Inc
Allergan Inamed Corporation
Barrier Therapeutics, Inc
Bayer AG
PharmaDerm Pharmaceuticals, Inc
Bristol-Myers Squibb
Collagenex (now Galderma) Pharmaceuticals
Galderma S.A
Genentech, Inc
GlaxoSmithKline Plc
Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
Medicis Pharmaceutical Corporation
Merck & Company, Inc
Mylan Pharmaceuticals, Inc,
Novartis Pharmaceuticals Corporation
Nycomed Inc
Pfizer, Inc
Q-Med AB
Roche Group (F. Hoffmann-La Roche Ltd.)
Schering (now Merck)-Plough Corporation
Sinclair Pharma Plc
SkinMedica
Stiefel Laboratories, Inc
Valeant Pharmaceuticals, Inc
APPENDIX: Company Directory
ReportsandReports comprising of an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. ReportsandReports announce to have
Market for Prescription Dermatological Drugs Market Research Report in its store. Browse all our
Market Research Reports details at ReportsandReports.com
Loading...
Search engine optimization is the process of choosing targeted keyword phrases related to a website, and ensuring that the website places well when those keyword phrases are part of a Web search.ON-PAGE OPTIMIZATION FACTORS:The Major Factors Are:Meta Tags......
If you are planning to open a coffee shop business then, the basic and foremost thing is to prepare a realistic and detailed business plan. It will be beneficial in number of ways: It helps you to accomplish your desired goals and objectives, to make impo......
Girlfriend Sayings
An Electric Car for the Family
Top 10 Beaches in the World
Top 10 European Ski Resorts
Top 10 High Demand High Paying Jobs in Australia
